Vergoeding 2015-2019 voor ATC-subgroep N06AX : Overige antidepressiva
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| N06AX03 Mianserine | 88.893 | 83.922 | 58.734 | 38.853 | 41.388 |
| N06AX05 Trazodon (Trazolan ®) | 558.300 | 574.870 | 523.650 | 544.550 | 559.120 |
| N06AX11 Mirtazapine (Remeron ®) | 1.714.900 | 1.787.500 | 1.781.100 | 1.544.200 | 1.519.300 |
| N06AX12 Bupropion (Wellbutrin ®) | 3.827.900 | 4.371.400 | 4.628.100 | 5.078.100 | 5.411.000 |
| N06AX16 Venlafaxine (Efexor ®) | 3.652.900 | 3.661.800 | 3.445.600 | 3.505.000 | 3.688.200 |
| N06AX21 Duloxetine (Cymbalta ®) | 7.576.900 | 4.567.500 | 3.275.000 | 2.970.000 | 1.739.400 |
| N06AX22 Agomelatine (Valdoxan ®) | 1.302.300 | 1.074.400 | 942.960 | 855.260 | 667.890 |
| N06AX26 Vortioxetine (Brintellix ®) | 283.990 | 639.430 | 824.390 | 1.065.800 | 1.376.500 |
| Totaal | 19.006.083 | 16.760.822 | 15.479.534 | 15.601.763 | 15.002.798 |